BRISTOL-MYERS SQUIBB COMPANY

BMY

CIK 0000014272 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$11.49B
↑+2.6% +$288Mvs FY2025 (Q1)
Operating Income
$3.18B
↑+6.7% +$200Mvs FY2025 (Q1)
Net Income
$2.68B
↑+9.0% +$221Mvs FY2025 (Q1)
Gross Profit
$8.07B
↓-1.2% -$100Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
15/100
  • Profitability
    0Insufficient data
  • Liquidity
    38Current Ratio 1.26 (above 1.5 = solid)
  • Leverage
    0D/E 2.43 (under 0.5 = conservative)
  • Efficiency
    25Asset Turnover 0.53x (1.0+ = capital-efficient)
  • Growth
    25Revenue YoY +2.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project BMY's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was 2.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$87.94
Total enterprise IV
$179.32B
Diluted shares
2.04B
Terminal PV
$126.36B (70% of total)
Year-5 FCF
$14.89B
YearProjected FCFDiscounted PV
+1$13.23B$12.03B
+2$13.63B$11.26B
+3$14.04B$10.55B
+4$14.46B$9.87B
+5$14.89B$9.25B
Terminal$203.51B$126.36B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$1.40B
investment in PP&E
Dividends paid (TTM)
$5.07B
cash returned to holders
Stock buybacks (TTM)
$0
share count reduction
Stock-based comp (TTM)
$555M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$86.48B
everything owned
Total liabilities
$66.37B
everything owed
Stockholders' equity
$20.07B
shareholder claim
Net debt
$34.57B
LT debt minus cash

Recent performance · 72 quarters

Revenue↑+2.6% +$288M
$11.49B
Net Income↑+9.0% +$221M
$2.68B
Free Cash Flow↓-55.3% -$937M
$757M
Operating Margin↑+1.0pts
26.7%

Drill down